Institut Curie Neuroblastoma Whole Genome Sequencing Diagnosis Relapse

DAC NAME AND ACCESSIONThis document specifies the policy for granting access to the European Genome-phenome Archive (EGA) secure Web based tools for managing data access permissions to the data stored in the EGA database. Access is granted to those Data Access Committee members named in this document by Paul Flicek, head of Genes, Genomes and Variation.Conditions of access:The account holder will abide by all current and future policies of the EBI for computer use as well as computer use policies of the European Molecular Biology Laboratory (EMBL), of which the EBI is a part. All EGA specific policies and standard operating procedures (SOPs) must also be followed. All applicable policies will be provided to the authorized users. Method of access:The EBI will create a personal account for the authorized person. The account username and password together with a RSA key provide access to the secure EGA infrastructure. A separate document with detailed guidelines on how to access and use these tools is provided to each account holder. The EGA help-desk provides training when needed.Review:All individuals will access to the EGA user authorization tools will be reviewed annually by Paul Flicek. Any staff changes affecting the authorized person must be provided immediately to Paul Flicek (flicek@ebi.ac.uk).Authorized Data Access Committee user:Gudrun SchleiermacherDépartement d'Oncologie Pédiatrique et INSERM U830 Institut Curie26 rue d'Ulm75248 Paris Cedex 05Francegudrun.schleiermacher@curie.frOlivier DelattreInstitut Curie – Centre de recherche – Unité U830 Inserm26 rue d'Ulm – 75248 Paris Cedex 05 Franceolivier.delattre@curie.frSupervisor of Authorized user:Olivier DelattreDirector of the Unit 830 Insermolivier.delattre@curie.fr